改良性保乳保腋窝手术与传统保乳手术对T1期乳腺癌患者复发的影响(1)
摘要：目的 对比改良性保乳保腋窝手术与传统保乳手术对T1期乳腺癌患者复发的影响。方法 选取2016年3月～2018年2月我院收治的T1期乳腺癌患者98例，按照随机数字表法分为观察组和对照组，各49例。观察组行改良性保乳保腋窝手术，对照组行传统保乳手术。对比两组手术相关指标、并发症及复发转移情况。结果 观察组手术时间、术中出血量、并发症发生率均优于对照组，差异有统计学意义(P<0.05);随访1年后，两组均未出现复发。结论 与传统保乳手术相比，改良性保乳保腋窝手术治疗T1期乳腺癌患者不会增加患者复发率，且可有效缩短手术时间，减少术中出血量，降低并发症发生率。
关键词：T1期乳腺癌;改良性保乳保腋窝手术;传统保乳手术;复发
中图分类号：R737.9 文獻标识码：A DOI：10.3969/j.issn.1006-1959.2019.11.034
, 百拇医药
文章编号：1006-1959(2019)11-0119-02
Abstract：Objective To compare the effects of modified breast-conserving axillary surgery and traditional breast-conserving surgery on the recurrence of T1 breast cancer patients.Methods A total of 98 patients with T1 breast cancer admitted to our hospital from March 2016 to February 2018 were enrolled. According to the random number table， the observation group and the control group were divided into 49 cases. The observation group underwent modified breast-conserving axillary surgery， and the control group underwent conventional breast-conserving surgery. The two groups of surgical related indicators， complications and recurrence and metastasis were compared.Results The operation time， intraoperative blood loss and complication rate of the observation group were superior to the control group，the difference was statistically significant(P<0.05). There was no recurrence in the two groups after 1 year of follow-up.Conclusion Compared with traditional breast-conserving surgery， modified breast-conserving axillary surgery for patients with T1 breast cancer does not increase the recurrence rate， and can effectively shorten the operation time， reduce the amount of intraoperative blood loss， and reduce the incidence of complications.
, 百拇医药
Key words：T1 breast cancer;Modified breast-preserving axillary surgery;Traditional breast-conserving surgery;Recurrence
近年来，随着临床检查技术不断发展，早期乳腺癌检出率明显增加，其中以T1期乳腺癌最为多见[1]。目前，临床上常采取保乳手术对T1期乳腺癌患者进行治疗，虽然可取得良好成效，但保乳手术对乳房缺损及腋窝淋巴结的处理问题仍存在争议[2]。近年来，改良性保乳保腋窝手术逐渐应用于临床，且取得良好成效。基于此，本研究主要对改良性保乳保腋窝手术与传统保乳手术对T1期乳腺癌患者复发的影响进行对比，以寻求最佳的治疗方法，现报道如下。
1资料与方法
1.1一般资料 选取2016年3月～2018年2月我院收治的T1期乳腺癌患者98例，均为女性，按照随机数字表法分为观察组和对照组，各49例。对照组年龄27～66岁，平均年龄(47.24±5.49)岁;肿瘤直径0.5～1.9 cm，平均直径(1.18±0.34)cm。观察组年龄29～65岁，平均年龄(46.85±5.37)岁;肿瘤直径0.5～2.0 cm，平均直径(1.22±0.36)cm。两组年龄、肿瘤直径等一般资料比较，差异无统计学意义(P>0.05)，有可比性。本研究经院内医学伦理委员会批准。, 百拇医药(石磊)
关键词：T1期乳腺癌;改良性保乳保腋窝手术;传统保乳手术;复发
中图分类号：R737.9 文獻标识码：A DOI：10.3969/j.issn.1006-1959.2019.11.034
, 百拇医药
文章编号：1006-1959(2019)11-0119-02
Abstract：Objective To compare the effects of modified breast-conserving axillary surgery and traditional breast-conserving surgery on the recurrence of T1 breast cancer patients.Methods A total of 98 patients with T1 breast cancer admitted to our hospital from March 2016 to February 2018 were enrolled. According to the random number table， the observation group and the control group were divided into 49 cases. The observation group underwent modified breast-conserving axillary surgery， and the control group underwent conventional breast-conserving surgery. The two groups of surgical related indicators， complications and recurrence and metastasis were compared.Results The operation time， intraoperative blood loss and complication rate of the observation group were superior to the control group，the difference was statistically significant(P<0.05). There was no recurrence in the two groups after 1 year of follow-up.Conclusion Compared with traditional breast-conserving surgery， modified breast-conserving axillary surgery for patients with T1 breast cancer does not increase the recurrence rate， and can effectively shorten the operation time， reduce the amount of intraoperative blood loss， and reduce the incidence of complications.
, 百拇医药
Key words：T1 breast cancer;Modified breast-preserving axillary surgery;Traditional breast-conserving surgery;Recurrence
近年来，随着临床检查技术不断发展，早期乳腺癌检出率明显增加，其中以T1期乳腺癌最为多见[1]。目前，临床上常采取保乳手术对T1期乳腺癌患者进行治疗，虽然可取得良好成效，但保乳手术对乳房缺损及腋窝淋巴结的处理问题仍存在争议[2]。近年来，改良性保乳保腋窝手术逐渐应用于临床，且取得良好成效。基于此，本研究主要对改良性保乳保腋窝手术与传统保乳手术对T1期乳腺癌患者复发的影响进行对比，以寻求最佳的治疗方法，现报道如下。
1资料与方法
1.1一般资料 选取2016年3月～2018年2月我院收治的T1期乳腺癌患者98例，均为女性，按照随机数字表法分为观察组和对照组，各49例。对照组年龄27～66岁，平均年龄(47.24±5.49)岁;肿瘤直径0.5～1.9 cm，平均直径(1.18±0.34)cm。观察组年龄29～65岁，平均年龄(46.85±5.37)岁;肿瘤直径0.5～2.0 cm，平均直径(1.22±0.36)cm。两组年龄、肿瘤直径等一般资料比较，差异无统计学意义(P>0.05)，有可比性。本研究经院内医学伦理委员会批准。, 百拇医药(石磊)